Tipsheet
What matters at India’s listed companies
Earnings · IT - Software · Micro cap

Xelpmoc's Q4 transcript adds nothing new beyond the concall summary.

The filing is a routine record of a June 1 earnings call. Management discussed operational performance and product updates for DocuXray and RELY.

1 earlier story on Xelpmoc Design And Tech Ltd.
Mkt cap₹139 cr
ROE0.00%
Debt / eq.0.00
Q4 FY26 The quarter under review in the backward-looking transcript.

What's new

  • Xelpmoc published the transcript for its Q4 FY26 earnings call held on June 1, 2026.
  • Management discussed operational performance, product developments for DocuXray and RELY, and portfolio company updates.
  • The filing is a backward-looking record with no material new information beyond the original call.

Why this matters

This is a procedural filing. The transcript is the official record of an event the market already digested on June 1. For investors, it offers a chance to review the exact wording of management's comments on DocuXray, RELY, and the portfolio, but it changes no near-term narrative.

What we're watching

  • The next quarterly results for FY27 to see if product developments in DocuXray and RELY translate to growth.
  • Any follow-on disclosures from the portfolio companies discussed.
  • The stock's reaction, if any, to this administrative release.

The full read

Xelpmoc filed the transcript for its Q4 FY26 earnings call, held on June 1, 2026. It's a procedural submission. The call itself, where management discussed operational performance and product updates for DocuXray and RELY, was the event. The market heard it then. This filing is the record. There are no revised numbers, no new guidance, and no surprises. For a stock, the transcript is a chance to revisit management's exact language. It doesn't change the story.

Questions answered

Why is Xelpmoc filing an earnings call transcript now?
Regulations require companies to file transcripts of their earnings calls. This filing is the formal, record-keeping submission for the call that took place on June 1, 2026.
What new products did management discuss?
The call included updates on the DocuXray and RELY products, along with a review of the company's portfolio of investments. The transcript itself does not add detail beyond what was said in the live call.
Does this filing contain any market-moving information?
No. The analyst rationale explicitly states the content contains no material surprises and was anticipated by the market. This is a backward-looking record of a past event.
Mentioned: Xelpmoc Design And Tech Ltd. · DocuXray · RELY
Primary source BSE · NSE · Tijori

An independent reading of the company's own disclosure — the primary filing above is the final word.

  1. 5 Jun 2026 · 5:08 PM IST Xelpmoc's Q4 transcript adds nothing new beyond the concall summary.
  2. 14d ago Xelpmoc takes Inqube Innoventures to NCLT